detalle del documento
IDENTIFICACIÓN

oai:arXiv.org:2404.05061

Tema
Computer Science - Computer Vision... Computer Science - Artificial Inte...
Autor
Nitzan, Shir Gilad, Maya Freiman, Moti
Categoría

Computer Science

Año

2024

fecha de cotización

10/4/2024

Palabras clave
breast cancer computer dwi 0 pcr
Métrico

Resumen

Effective surgical planning for breast cancer hinges on accurately predicting pathological complete response (pCR) to neoadjuvant chemotherapy (NAC).

Diffusion-weighted MRI (DWI) and machine learning offer a non-invasive approach for early pCR assessment.

However, most machine-learning models require manual tumor segmentation, a cumbersome and error-prone task.

We propose a deep learning model employing "Size-Adaptive Lesion Weighting" for automatic DWI tumor segmentation to enhance pCR prediction accuracy.

Despite histopathological changes during NAC complicating DWI image segmentation, our model demonstrates robust performance.

Utilizing the BMMR2 challenge dataset, it matches human experts in pCR prediction pre-NAC with an area under the curve (AUC) of 0.76 vs. 0.796, and surpasses standard automated methods mid-NAC, with an AUC of 0.729 vs. 0.654 and 0.576.

Our approach represents a significant advancement in automating breast cancer treatment planning, enabling more reliable pCR predictions without manual segmentation.

;Comment: Accepted for presentation at the IEEE International Symposium on Biomedical Imaging (ISBI)

Nitzan, Shir,Gilad, Maya,Freiman, Moti, 2024, Automated Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy from DWI Data

Documento

Abrir

Compartir

Fuente

Artículos recomendados por ES/IODE IA

Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
agphd1 subtypes replication hykk squamous cell gene carcinoma causal targets mendelian randomization cancer analysis